arrow
返回
E

Elias Jabbour

The University of Texas MD Anderson Cancer Center

115H指数
2.3K论文数
5.5W被引数
收录论文 482
发表时间
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia新诊断急性髓系白血病中NPM1突变相关的临床结局
errCancer
IF5.1
err2026-08-13
err0
errOAAI
errAziz Farhat MD; Georgina El Hajjar MD; Hagop Kantarjian MD; Koji Sasaki MD, PhD; Nicholas J. Short MD; Branko Cuglievan MD; Sanam Loghavi MD; Keyur Patel MD, PhD; Alex Bataller MD, PhD; Wei Ying Jen MA, BMBCh, MRCP, MMed, FRCPath; Musa Yilmaz MD; Guillermo Montalban-Bravo MD; Danielle Hammond MD; Naveen Pemmaraju MD; Naval Daver MD; Farhad Ravandi MD; Elias Jabbour MD; Tapan Kadia MD; Gautam Borthakur MD; Guillermo Garcia-Manero MD; Courtney D. DiNardo MD; Ghayas C. Issa MD, MS
err分享
err收藏
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia比较obeccabtagene autoleucel与外部对照臂在复发/难治性B细胞急性淋巴细胞白血病患者中的疗效
errLeukemia
IF13.4
err2026-07-17
err0
errOAAI
errMax S. Topp; Bijal D. Shah; Elias Jabbour; Jae H. Park; Paul Shaughnessy; Aaron C. Logan; Karamjeet S. Sandhu; Mehrdad Abedi; Michael R. Bishop; Daniel J. DeAngelo; Xiang Yin; Ruthanna Davi; Katharine Hodby; Ram Malladi; Wolfram Brugger; Justin Shang; Claire Roddie; Hagop M. Kantarjian
err分享
err收藏
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage成人B细胞急性淋巴细胞白血病患者在首次挽救治疗中使用blinatumomab和/或inotuzumab ozogamicin的生存预测因子
errLeukemia
IF13.4
err2026-07-16
err0
errOAAI
errRoberta S. Azevedo; Elias Jabbour; Nitin Jain; Fadi G. Haddad; Partow Kebriaei; Issa Khouri; Elizabeth J. Shpall; Richard Champlin; Omer Karrar; Manuel Maroun; Jayastu Senapati; Eitan Kugler; Rebecca S. Garris; Farhad Ravandi; Hagop Kantarjian; Nicholas J. Short
err分享
err收藏
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia奥佐米星依诺他单抗疗法治疗成人急性淋巴细胞白血病的可测量残留病灶
err2026-06-27
err0
errOAAI
errElias Jabbour; Caitlin R. Rausch; Hannah Goulart; Nitin Jain; Farhad Ravandi; Abhishek Maiti; Yesid Alvarado; Jan Burger; Musa Yilmaz; Issa Khouri; Partow Kebriaei; Jeffrey Jorgensen; Sa A. Wang; Xuemei Wang; Ejiroghene Mayor; Rebecca S. Garris; Nicholas J. Short; Hagop Kantarjian
err分享
err收藏
Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia奥佐米星在唐氏综合征和急性淋巴细胞白血病患者中的应用
errLeukemia
IF13.4
err2026-06-03
err0
PREAI
errAmanda M. Li; Catherine Aftandilian; Colleen Annesley; Susan Colace; Kelly E. Faulk; Joshua W. Goldman; Erin Guest; Ammar Hayani; Richard Ho; Elias Jabbour; Anjali Khanna-Farber; Wade Kyono; Kasey Leger; Kelly Maloney; David McCall; Tamara Miller; Holly L. Pacenta; Troy C. Quigg; Jeremy D. Rubinstein; Eric Schafer; Susan R. Rheingold; Deepa Bhojwani; Maureen M. O’Brien; Karen R. Rabin
err分享
err收藏
Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALLPh1阴性B-ALL一线治疗使用blinatumomab后复发的预测因素及复发后结局
err2026-05-17
err0
errOAAI
errSankalp Arora; Hagop Kantarjian; Koji Sasaki; Nitin Jain; Zhouxuan Li; Wei Qiao; Sanam Loghavi; Guilin Tang; Caitlin Rausch; Farhad Ravandi; Fadi G. Haddad; Jayastu Senapati; Guillermo Montalban Bravo; Alexandre Bazinet; Rita Khouri; Rebecca Garris; Guillermo Garcia-Manero; Nicholas J. Short; Elias Jabbour
err分享
err收藏
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy低强度治疗下急性髓系白血病中ASXL1突变的预后影响
errCancer
IF5.1
err2026-05-06
err0
errOAAI
errJennifer Marvin-Peek MD; Courtney D. DiNardo MD, MSCE; Sanam Loghavi MD; Farhad Ravandi MD; Gautam Borthakur MD; Naval G. Daver MD; Tapan M. Kadia MD; Elias Jabbour MD; Andrew Dunbar MD; Guilin Tang MD, PhD; Nicholas J. Short MD; Fadi G. Haddad MD; Hussein A. Abbas MD, PhD; Eitan Kugler MD; Abhishek Maiti MD; Ghayas C. Issa MD; Koichi Takahashi MD, PhD; Kapil Bhalla MD; Naveen Pemmaraju MD; Yesid Alvarado MD; Elizabeth J. Shpall MD; Uday Popat MD; Jeremy Ramdial MD; Richard E. Champlin MD; Hagop M. Kantarjian MD; Guillermo Garcia-Manero MD; Jayastu Senapati MD, DM
err分享
err收藏
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia成人B细胞急性淋巴细胞白血病的二线治疗结局
errCancer
IF5.1
err2026-04-09
err0
PREAI
errHagop Kantarjian MD; Wei Qiao MS, PhD; Nitin Jain MD; Wei-Ying Jen MD; Eitan Kugler MD; Nicholas J. Short MD; Rebecca Garris RN; Sherry Pierce RN; Partow Kebriaei MD; Sa A. Wang MD; Fadi Haddad MD; Farhad Ravandi MD; Xuelin Huang PhD; Elias Jabbour MD
err分享
err收藏
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes异基因造血干细胞移植对高风险骨髓增生异常综合征患者的影响
err2026-03-27
err0
errOAAI
errAlexandre Bazinet; Alex Bataller; Kelly Chien; Koji Sasaki; Guillermo Montalban-Bravo; Danielle Hammond; Ian Bouligny; Mahesh Swaminathan; Wei Ying Jen; Eitan Kugler; Rashmi Kanagal-Shamanna; Tapan Kadia; Gautam Borthakur; Courtney DiNardo; Nicholas Short; Naveen Pemmaraju; Elias Jabbour; Naval Daver; Farhad Ravandi; Samuel Urrutia; Georgina Gener-Ricos; Julie Braish; Robert Briski; Juan Jose Rodriguez-Sevilla; Ziyi Li; Richard E. Champlin; Elizabeth J. Shpall; Amin Alousi; Betul Oran; Chitra Hosing; Jeremy L. Ramdial; Amanda Olson; Sherry Pierce; Julianne Chen; Hagop Kantarjian; Guillermo Garcia-Manero; Uday Popat
err分享
err收藏
The Care and Cure of the Leukemias in 20262026年白血病的管理与治疗
err2026-02-27
err0
PREAI
errHagop Kantarjian; Helen T. Chifotides; Fadi G. Haddad; Elias Jabbour; Nitin Jain; Tapan Kadia; Farhad Ravandi; Mary Alma Welch; William Wierda; Emil J. Freireich
err分享
err收藏
Acute Leukemia with BCL11B Rearrangements: Genetic Landscape, BCL11B Expression, and Therapeutic Response,
err2026-01-23
err0
PREAI
errGuilin Tang; Sa A. Wang; Wei Ying Jen; L.Jeffrey Medeiros; Wei Wang; Hong Fang; Shimin Hu; Nitin Jain; Elias Joseph Jabbour; Ying S. Zou; Jie Xu
err分享
err收藏
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia更正:维奈克拉联合FLAG-IDA诱导和巩固治疗新诊断及复发或难治性急性髓系白血病的长期结果
errLeukemia
IF13.4
err2025-12-10
err0
errOAAI
errCourtney D. DiNardo; Wei-Ying Jen; Koichi Takahashi; Tapan M. Kadia; Sanam Loghavi; Naval G. Daver; Lianchun Xiao; Patrick K. Reville; Ghayas C. Issa; Nicholas J. Short; Koji Sasaki; Sa A. Wang; Jillian K. Mullin; Sherry Pierce; Corey Bradley; Gautam Borthakur; Abhishek Maiti; Yesid Alvarado; Naveen Pemmaraju; Alessandra Ferrajoli; Mahesh Swaminathan; Maro Ohanian; Hussein A. Abbas; Danielle Hammond; Jan Burger; Fadi Haddad; Guillermo Montalban-Bravo; Kelly Chien; Lucia Masarova; Musa Yilmaz; Nitin Jain; Michael Andreeff; Guillermo Garcia-Manero; Steven Kornblau; Farhad Ravandi; Elias Jabbour; Marina Y. Konopleva; Hagop M. Kantarjian
err分享
err收藏
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemiasDS-1594 menin抑制剂的1/2期研究:在复发/难治性急性白血病中的应用
err2025-11-27
err0
errOAAI
errJayastu Senapati; Marina Konopleva; Ghayas C. Issa; Elias Jabbour; Tapan Kadia; Courtney DiNardo; Gautam Borthakur; Naveen Pemmaraju; Nicholas J. Short; Musa Yilmaz; Indraneel Deshmukh; Joie Alvarez; Sanam Loghavi; Guilin Tang; Hussein A. Abbas; Michael Andreeff; Kapil Bhalla; Narasimha M. Midde; Nabil Said; Amy Noyalis; Derek E. Mires; Jing Ning; Lianchun Xiao; Farhad Ravandi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Naval G. Daver
err分享
err收藏
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes混合表型急性白血病伴TP53突变:遗传景观、治疗反应和预后
err2025-11-06
err0
errOAAI
errWei J. Wang; Qiudan Shen; Mehrnoosh Tashakori; Hong Fang; Wen Shuai; Pei Lin; Zhaoxuan Zhang; Guilin Tang; Wei Wang; Michael A. Linden; Elias J. Jabbour; Tapan M. Kadia; Nicholas J. Short; Naval G. Daver; L. Jeffrey Medeiros; Shimin Hu
err分享
err收藏
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens2025年白血病研究进展回顾:通过MD Anderson白血病研究视角进行审视
errCancer
IF5.1
err2025-10-23
err0
errOAAI
errHagop M. Kantarjian MD; Gautam Borthakur MD; Naval Daver MD; Courtney DiNardo MD; Guillermo Garcia-Manero MD, MMSc; Ghayas Issa MD; Elias Jabbour MD; Nitin Jain MD; Tapan Kadia MD; Sanam Loghavi MD; Farhad Ravandi MD; Guilin Tang MD, PhD; Mary Alma Welch MMSc; William Wierda MD, PhD
err分享
err收藏
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL新诊断B细胞急性淋巴细胞白血病中早期NGS MRD动态及细胞分子风险对预后的影响
err2025-10-21
err0
errOAAI
errNicholas J. Short; Elias Jabbour; Walid Macaron; Nitin Jain; Fadi G. Haddad; Sanam Loghavi; Tapan M. Kadia; Partow Kebriaei; Eitan Kugler; Jairo Matthews; Rebecca Garris; Farhad Ravandi; Hagop Kantarjian
err分享
err收藏
The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study扩大巴西、格鲁吉亚、肯尼亚和南非的结核病筛查和预防性治疗的有效性、成本效益、预算影响和投资回报:一项模型研究
err2025-10-15
err0
errOAAI
errJuan F Vesga; Mona Salaheldin Mohamed; Monica Shandal; Elias Jabbour; Nino Lomtadze; Mmamapudi Kubjane; Anete Trajman; Gesine Meyer-Rath; Zaza Avaliani; Wesley Rotich; Daniel Mwai; Julio Croda; Hlengani T Mathema; Immaculate Kathure; Rhoda Pola; Fernanda Dockhorn Costa; Norbert O Ndjeka; Maka Danelia; Maiko L Tonini; Nelly Solomonia; Daniele M Pelissari; Dennis Falzon; Cecily Miller; Ines Garcia Baena; Nimalan Arinaminpathy; Kevin Schwartzman; Saskia Den Boon; Jonathon R Campbell
err分享
err收藏
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemiaCladribine、高剂量cytarabine,以及gemtuzumab ozogamicin(CLAG-GO)作为core-binding factor急性髓系白血病适合患者的初始强化治疗。
err2025-10-01
err0
PREAI
errAzevedo, Roberta S.; Braish, Julie; Gener-Ricos, Georgina; Tang, Guilin; Sasaki, Koji; Montalban-Bravo, Guillermo; Jabbour, Elias; Ohanian, Maro; Yilmaz, Musa; Haddad, Fadi G.; Chien, Kelly; Ishizawa, Jo; Short, Nicholas J.; Maiti, Abhishek; Swaminathan, Mahesh; Kantarjian, Hagop; Borthakur, Gautam; Kadia, Tapan M.
err分享
err收藏